Toumaz Technology Debuts New Multi-Function Sensium Module

Toumaz Technology LimitedToumaz Technology Limited has announced the first availability of the Sensiumâ„¢ modular system, a new ultra-low power wireless infrastructure for health and lifestyle monitoring applications. The wireless-enabled modules, based on Toumaz's ultra-low power Zoum transceiver platform, are being made available now to key customers. The first demonstration of the new modular system took place on the Oracle stand at The World of Health IT Conference and Exhibition in Geneva, Switzerland (Geneva Palexpo, 10th-13th October 2006, Oracle stand #315).

The ultra small size body-worn module can be attached to the body with a sticking plaster to enable non-intrusive, continuous monitoring and analysis of the mobile individual's ECG, temperature, and at least one other vital sign such as respiration or activity level. The wearable sensor module incorporates Toumaz's ultra low power Zoum RF transceiver to create a wireless data link and transmit personal readings on to a Zoum-enabled SD card or USB module. The SD card plugs into any standard PDA or cellphone running Windows Mobile 5, allowing the ECG, temperature and other vital sign data to be received, processed and displayed via Toumaz's ECGSoft application software. A sophisticated, real-time arrhythmia detection algorithm continuously analyses the incoming data to provide an intelligent ECG monitoring capability.

Due to the ultra low power Zoum transceiver, incorporating both RF and baseband functionality such as framing, error correction and link protocol, the body-worn Sensium module is able to be manufactured in a small, non-intrusive form factor that can use a small, low cost zinc-air battery to provide multi-function continuous monitoring for an average of five days.

"The Sensium module is delivering the wireless infrastructure for a new wave of personalised care applications, and is now set to enable a real revolution in areas such as continuous vital sign monitoring," commented Toumaz COO, Keith Errey. "By integrating with standard mobile devices such as PDAs and cellphones, the Sensium is defining new possibilities for low cost, disposable monitoring solutions for a whole range of healthcare applications, including 'at risk', post-operative and home monitoring".

The 'digital plaster' concept pioneered by Toumaz has attracted significant interest within the healthcare market. Toumaz Chairman and Chief Technology Officer, Professor Chris Toumazou delivered an e-Session on Pervasive Monitoring Technologies for Personalised Healthcare at The World of Health IT Conference and Exhibition in Geneva.

For further information, please visit:
www.toumaz.com/healthcare/

Related news articles:

About Toumaz Technology
Toumaz Technology Limited is a developer of advanced RF, analogue and mixed signal semiconductors. The focus of the business is low power devices based on the company's proprietary AMx (Advanced Mixed Signal) technology which addresses the needs of lower power consumption for mobile and wirelessly connected systems.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...